ChromaDex Corporation (NASDAQ:CDXC) Q3 2020 Earnings Conference Call November 4, 2020 4:30 PM ET Company Participants Brianna Gerber – Vice President-FP&A and Investor Relations Rob Fried – Chief Executive Officer Frank Jaksch – Co-Founder and Executive Chairman Kevin Farr – Chief Financial Officer Conference Call Participants Jeffrey Cohen – Ladenburg Brian Nagel – Oppenheimer Jeff Van Sinderen – B. Riley FBR Ram Selvaraju – H.C. Wainwright Mitchell Pinheiro – Sturdivant & Company JP Mark – Farmhouse Equit ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 26-2940963 (State incorporation or (I.R.S. Employer Identification No.) orotherjurisdictionof organization) 10900 Wilshire Blvd. Suite 600, Los Angeles, CA (Address of Pr ...

ChromaDex Corporation (NASDAQ:CDXC) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Brianna Gerber - Vice President, FP&A & Investor Relations Rob Fried - Chief Executive Officer Frank Jaksch - Founder & Executive Chairman Kevin Farr - Chief Financial Officer Conference Call Participants Jeff Vansen Sinderen - B. Riley Brian Nagel - Oppenheimer Mitchell Pinheiro - Sturdivant JP Mark - Farmhouse Equity Research Matt Dhane - Tieton Capital Management Operator Ladies and gentlem ...

ChromaDex Earnings Conference Call Second Quarter 2020 Rob Fried Chief Executive Officer Frank Jaksch Co-Founder / Executive Chairman Kevin Farr Chief Financial Officer Nasdaq: CDXC | August 6, 2020 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-l ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | |-------------|--------------------------------------------------------------| | | Delaware | | (State or | other jurisdiction of incorporation or organization) | 26-2940 ...

Investor Presentation Rob Fried Chief Executive Officer Kevin Farr Chief Financial Officer TRU NIAGEN Nasdaq: CDXC | June 2020 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements reflect the current view about future events. Statemen ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 26-2940963 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 10900 Wilshire Blvd. Suite 600 Los Angeles, California 9002 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.001 par value per share CDXC The Nasdaq Capital Market FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2019 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 26-2940963 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 10900 Wilshire Blvd. Suite 600 Los Angeles, California ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 26-2940963 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 10900 Wilshire Blvd. Suite 650, Los Angeles, California (Add ...